{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T13:49:16Z","timestamp":1787060956588,"version":"build-2736575974"},"reference-count":17,"publisher":"Cardiofront, LLC","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.4022\/jafib.1805","type":"journal-article","created":{"date-parts":[[2018,2,19]],"date-time":"2018-02-19T04:47:49Z","timestamp":1519015669000},"source":"Crossref","is-referenced-by-count":13,"title":["Safety and Efficacy of Inpatient Initiation of Dofetilide versus Sotalol for atrial fibrillation"],"prefix":"10.4022","volume":"10","author":[{"given":"Dhanunjaya","family":"Lakkireddy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2440","published-online":{"date-parts":[[2017,12,31]]},"reference":[{"key":"key_R01","first-page":"719","article-title":"Antiarrhythmic drugs for maintaining sinus rhythm after cardioversion of atrial fibrillation: a systematic review of randomized controlled trials.","volume-title":"Circulation","year":"2006"},{"key":"key_R02","first-page":"e257","article-title":"ACC\/AHA\/ESC 2006 Guidelines for the Management of Patients with Atrial Fibrillation: a report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients With Atrial Fibrillation): developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society.","volume-title":"J Am Coll Cardiol","year":"2006"},{"key":"key_R03","first-page":"632","article-title":"2012 HRS\/EHRA\/ECAS expert consensus statement on catheter and surgical ablation of atrial fibrillation: recommendations for patient selection, procedural techniques, patient management and follow-up, definitions, endpoints, and research trial design: a report of the Heart Rhythm Society (HRS) Task Force on Catheter and Surgical Ablation of Atrial Fibrillation. Developed in partnership with the European Heart Rhythm Association (EHRA), a registered branch of the European Society of Cardiology (ESC) and the European Cardiac Arrhythmia Society (ECAS); and in collaboration with the American College of Cardiology (ACC), American Heart Association (AHA), the Asia Pacific Heart Rhythm Society (APHRS), and the Society of Thoracic Surgeons (STS). Endorsed by the governing bodies of the American College of Cardiology Foundation, the American Heart Association, the European Cardiac Arrhythmia Society, the European Heart Rhythm Association, the Society of Thoracic Surgeons, the Asia Pacific Heart Rhythm Society, and the Heart Rhythm Society.","volume":"9 (4)","year":"2012","journal-title":"Policy guidance (accessed 30 June 2016)."},{"key":"key_R04","first-page":"262","article-title":"Controversies in atrial fibrillation.","volume":"367 (9506):","year":"2004","journal-title":"Lancet"},{"key":"key_R05","first-page":"386","article-title":"The cardiac arrhythmia suppression trial (CAST).","volume":"321 (6)","year":"1989","journal-title":"N. Engl. J. Med."},{"key":"key_R06","first-page":"109F","article-title":"Preliminary results of the Cardiac Arrest Study Hamburg (CASH). CASH Investigators.","volume":"72 (16)","year":"1993","journal-title":"Am. J. Cardiol."},{"key":"key_R07","first-page":"913","article-title":"Amiodarone to prevent recurrence of atrial fibrillation. Canadian Trial of Atrial Fibrillation Investigators.","volume":"342 (13)","year":"2000","journal-title":"N. Engl. J. Med"},{"key":"key_R08","first-page":"20","article-title":"Maintenance of sinus rhythm in patients with atrial fibrillation: an AFFIRM substudy of the first antiarrhythmic drug.","volume":"42 (1)","year":"2003","journal-title":"J. Am. Coll. Cardiol"},{"key":"key_R09","first-page":"1861","article-title":"Amiodarone versus sotalol for atrial fibrillation.","volume":"352 (18)","year":"2005","journal-title":"N. Engl. J. Med."},{"key":"key_R10","first-page":"2030","article-title":"Long-term efficacy and safety of very-low-dose amiodarone treatment for the maintenance of sinus rhythm in patients with chronic atrial fibrillation after successful direct-current cardioversion.","volume":"119 (24)","year":"2006","journal-title":"Chin. Med. J."},{"key":"key_R11","first-page":"e1","article-title":"2014 AHA\/ACC\/HRS guideline for the management of patients with atrial fibrillation: a report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society.","volume":"64 (21)","year":"2014","journal-title":"J. Am. Coll. Cardiol."},{"key":"key_R12","first-page":"292","article-title":"Efficacy of dofetilide in the treatment of atrial fibrillation-flutter in patients with reduced left ventricular function: a Danish investigations of arrhythmia and mortality on dofetilide (diamond) substudy.","volume":"104 (3)","year":"2001","journal-title":"Circulation"},{"key":"key_R13","first-page":"1855","article-title":"Prevention of implantable-defibrillator shocks by treatment with sotalol. d,l-Sotalol Implantable Cardioverter-Defibrillator Study Group.","volume":"340 (24)","year":"1999","journal-title":"N. Engl. J. Med."},{"key":"key_R14","first-page":"121","article-title":"Pharmacologic conversion of atrial fibrillation: a systematic review of available evidence.","volume":"44 (2)","year":"2001","journal-title":"Prog Cardiovasc Dis"},{"key":"key_R15","first-page":"490","article-title":"Risk prediction for adverse events during initiation of sotalol and dofetilide for the treatment of atrial fibrillation.","volume":"38 (4)","year":"2015","journal-title":"Pacing Clin Electrophysiol"},{"key":"key_R16","first-page":"840","article-title":"Cost of hospital admission for antiarrhythmic drug initiation in atrial fibrillation.","volume":"43 (5)","year":"2009","journal-title":"Ann Pharmacother"},{"key":"key_R17","first-page":"117","article-title":"Meta-analysis of the Risk of Torsades de Pointes in patients treated with intravenous racemic sotalol.","volume":"8 (2)","year":"2001","journal-title":"Acad Emerg Med"}],"container-title":["Journal of Atrial Fibrillation"],"original-title":[],"language":"en","deposited":{"date-parts":[[2018,2,19]],"date-time":"2018-02-19T04:47:49Z","timestamp":1519015669000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.jafib.com\/published.php?type=full&id=1805"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,12]]},"references-count":17,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2017,12,31]]},"published-print":{"date-parts":[[2017,12]]}},"alternative-id":["10.4022\/jafib.1805"],"URL":"https:\/\/doi.org\/10.4022\/jafib.1805","relation":{},"ISSN":["1941-6911"],"issn-type":[{"value":"1941-6911","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,12]]},"article-number":"1805"}}